Regenxbio (RGNX) Net Cash Flow (QoQ) (2015 - 2025)
Regenxbio (RGNX) Net Cash Flow (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17.25% |
| Sep 30, 2025 | 58.94% |
| Jun 30, 2025 | -169.64% |
| Mar 31, 2025 | 7,884.38% |
| Dec 31, 2024 | 179.18% |
| Sep 30, 2024 | 97.92% |
| Jun 30, 2024 | -170.37% |
| Mar 31, 2024 | 518.46% |
| Dec 31, 2023 | -20.53% |
| Sep 30, 2023 | -1,128.67% |
| Jun 30, 2023 | 95.29% |
| Mar 31, 2023 | -24.40% |
| Dec 31, 2022 | -662.97% |
| Sep 30, 2022 | 95.99% |
| Jun 30, 2022 | 54.02% |
| Mar 31, 2022 | -230.47% |
| Dec 31, 2021 | 509.70% |
| Sep 30, 2021 | 16.64% |
| Jun 30, 2021 | 26.70% |
| Mar 31, 2021 | -119.14% |